From GLP-1 therapies to next-generation treatments and long-term weight management
Watch the full video on YouTube to explore the future of anti-obesity medications and emerging therapeutic strategies.
In this episode, experts, Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías discuss the rapid evolution of obesity pharmacotherapy, from GLP-1 receptor agonists to next-generation combination treatments and oral therapies.
Key topics include:
The shift from injectable to oral and longer-acting medications
Multi-agonist therapies targeting multiple metabolic pathways
The importance of “quality weight loss” and preserving muscle mass
Challenges in long-term weight maintenance and preventing regain
The role of lifestyle intervention alongside pharmacotherapy
Future targets, including metabolic “set point” regulation
Explore more about the speakers:
Dr Daniela Liśkiewicz
Dr Juan Pablo Frias
For more episodes, visit our podcast archive.
